πŸ‡ΊπŸ‡Έ FDA
Patent

US 12102688

Immunomodulatory nanofilaments

granted A61KA61K47/56A61K47/64

Quick answer

US patent 12102688 (Immunomodulatory nanofilaments) held by Stichting Radboud universitair medisch centrum expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Stichting Radboud universitair medisch centrum
Grant date
Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K47/56, A61K47/64, A61K47/6813, A61K47/6849